| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020732 |
| Receipt No. | R000022198 |
| Official scientific title of the study | An exploratory clinical trial for the congenital melanocytic nevi using the noble combination therapy with the inactivated autologous nevus tissue by high hydrostatic pressure and the cultured epithelial autograft |
| Date of disclosure of the study information | 2016/01/26 |
| Last modified on | 2019/01/26 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | An exploratory clinical trial for the congenital melanocytic nevi using the noble combination therapy with the inactivated autologous nevus tissue by high hydrostatic pressure and the cultured epithelial autograft | |
| Title of the study (Brief title) | The noble combination therapy with the inactivated nevus tissue by high hydrostatic pressure and the cultured epithelial autograft | |
| Region |
|
|
| Condition | ||
| Condition | Melanocytic nevi | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Exploration of the take of the pressurized nevus in comnination with the cultured epidermal autograft |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase I,II |
| Assessment | |
| Primary outcomes | The take of inactivated nevus with cultured epidermal autograft at 8weeks after implantation |
| Key secondary outcomes | Adverse events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Apply cultured epidermal autografts on the pressirized nevusApply on the wound after the removal of the nevus | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients with congenital pigmented nevus that can not be excised and sutured primarily
2.The area of the nevus is more than 0.25% of the body surface area 3.Operable patients more than 7 months old and 4.Written informed consent |
|||
| Key exclusion criteria | 1.Patients with scar tissue that prevent the take of inactivated nevus
2.The nevus that has been treated by cultured epidermal autografts already. 3.A history of malignant tumor with disease free interval of 5 years or less 4.Other patients judged by the investigator or sub-investigator to be inappropriate as a subject of this study. 5.Patients who have received this protocol treatments twice. |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Naoki Morimoto |
| Organization | Kansai Medical University |
| Division name | Department of Plastic and Reconstructive Surgery |
| Address | 2-5-1 Shin-machi, Hirakata City, Osaka |
| TEL | 072-804-0101 |
| morimotn@hirakata.kmu.ac.jp | |
| Public contact | |
| Name of contact person | Omura Miyuki |
| Organization | Kansai Medical University |
| Division name | Center for Clinical Research |
| Address | 2-5-1 Shin-machi, Hirakata City, Osaka |
| TEL | 072-804-0101 |
| Homepage URL | http://www5.kmu.ac.jp/prs/index.html |
| kmuccr@hirakata.kmu.ac.jp | |
| Sponsor | |
| Institute | Department of Plastic and Reconstructive Surgery, Kansai Medical University
|
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 関西医科大学附属枚方病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022198 |